This website uses cookies

This website uses cookies to ensure you get the best experience. By using our website, you agree to our Privacy Policy

International In-house Counsel Journal logoInternational In-house Counsel Journal logo

Digital Media in the Pharmaceutical Industry: Oportunities and Legal Challenges

Abstract

The term digital media is widely understood. According to the open-access encyclopedia Wikipedia digital media shall mean a “form of electronic media where data are stored in digital (as opposed to analog) form and can include the technical aspect of storage and transmission (e.g. hard disk drives or computer networking) of information or to the "end product", such as digital video, augmented reality, digital signage, digital audio, or digital art.” The focus of the following discussion will be on the transmission of information for example by websites and digital communication tools as well as on the use of “end products” like augmented reality applications.

Read Paper

Author

Portrait image of Marc Bauer
Marc Bauer
Legal Director, AMGEN (Europe) GmbH, Switzerland

Dr Marc Bauer is a Director & Senior Legal Counsel with Amgen based in Zug. Before joining Amgen he was 6 years as an external counsel with the international law firm HoganLovells where he advised clients in the pharmaceutical and medical devices industry on all commercial matters including Compliance. The author is part of the International Legal Team covering all markets outside the US. The author leads the support of the commercial functions within Amgen, including marketing, 3rd party relationships and International litigations. He is also part of Amgen's digital media council.

Company

AMGEN (Europe) GmbH

Amgen is the largest independent Biotech company in the world.

Related Papers

Pharmaceutical Marketing and Transparency in Japan
Japan is a promising market for companies, in-spite of the pressures posed by drug prices, competition and patents. The reason may be the large growth of pharmaceuticals, an aging population,...Read more
Portrait image of Marianne Slivkova
Marianne Slivkova
Senior Corporate Counsel, Acorda Therapeutics, USA
Patent Strategies for Attenuated Pathogen Vaccines
Malaria is a major health concern for people traveling to and living in malaria-endemic areas, causing 249 million clinical cases and 608,000 deaths in 2022, numbers essentially unchanged over the...Read more
Portrait image of David Dolberg
David Dolberg
Senior Director of Intellectual Property, Sanaria Inc., USA
Ways to Avoid Having your Patents Cellected*
The Court of Appeals for the Federal Circuit caused frustrations when it decided to affirm the U.S. Patent Office’s findings that claims in four patents were unpatentable because they are...Read more
Portrait image of Tom Irving
Tom Irving
Partner, Marbury Law Group, USA
Portrait image of Michelle E. O'Brien
Michelle E. O'Brien
Partner, Marbury Law Group, USA
Portrait image of Xiaoguang Michelle Gao
Xiaoguang Michelle Gao
Associate VP - Assistant General Patent Counsel , Eli Lilly and Company, USA
Supported Studies Quid Pro Quo
Many pharmaceutical companies (hereinafter Companies or Company) recognize the importance of supporting external studies and the role they play in fulfilling patients’ needs. High standard ethical research conducted by external...Read more
Portrait image of Ann Turi
Ann Turi
Senior Legal Counsel, Legal and Compliance R&D and Medical Legal Team, Gsk, USA